Federal Register / Vol. 75, No. 46 / Wednesday, March 10, 2010 / Notices 11189 

Date: April 12, 2010. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892. (Telephone 

Conference Call.) 

Contact Person: Robert Wellner, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes Of Health, 

Room 757, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452. (301) 594–4721. 

rw175w@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: March 3, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–5019 Filed 3–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Cellular and Developmental 

Neuroscience. 

Date: March 24, 2010. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Deborah L. Lewis, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4183, 

MSC 7850, Bethesda, MD 20892, 301–408– 

9129, lewisdeb@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 2, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–5018 Filed 3–9–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Bureau of Health Professions; All 

Advisory Committee Meeting; Notice of 

Meeting 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), notice is hereby given 

of the following meeting: 

Name: Bureau of Health Professions AllAdvisory Committee Meeting (AACM). 

Dates and Times: April 21, 2010, 8 a.m.– 

5 p.m. 

Place: Doubletree Hotel & Executive 

Meeting Center, 8120 Wisconsin Avenue, 

Bethesda, MD 20814. 

Telephone: 301–652–2000. 

Status: The meeting will be open to the 

public. 

Purpose: The purpose of the meeting is to 

provide a venue for the Bureau of Health 

Professions’ (BHPr) four advisory committees 

[the Council on Graduate Medical Education 

(COGME), the Advisory Committee on 

Training in Primary Care Medicine and 

Dentistry (ACTPCMD), the Advisory 

Committee on Interdisciplinary, CommunityBased Linkages (ACICBL), and the National 

Advisory Council on Nurse Education and 

Practice (NACNEP)] to continue their joint 

work on interdisciplinary education and 

practice, and to also discuss and identify 

future opportunities for collaboration. 

Agenda: The AACM agenda will include 

updates on Bureau and Departmental 

priorities, discussion of the joint work on 

interdisciplinary education and practice, and 

proposals for future Advisory Committee 

collaboration. Agenda items are subject to 

change as priorities dictate. 

For Further Information Contact: 

Anyone interested in obtaining a roster of 

members, minutes of the meeting, or other 

relevant information can contact the Bureau 

of Health Professions, Office of the Associate 

Administrator, 5600 Fishers Lane, room 9– 

05, Rockville, Maryland, 20857, telephone 

(301) 443–5794. Information can also be 

found at the following Web site: http:// 

bhpr.hrsa.gov/. 

Dated: March 2, 2010. 

Sahira Rafiullah, 

Director, Division of Policy and Information 

Coordination. 

[FR Doc. 2010–5006 Filed 3–9–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0107] 

Expanded Access to Direct-Acting 

Antiviral Agents for the Treatment of 

Chronic Hepatitis C Infection in 

Patients With Unmet Medical Need; 

Public Hearing; Request for Comments 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice of public hearing; request 

for comments. 

SUMMARY: The Food and Drug 

Administration (FDA or the agency) is 

announcing a public hearing to obtain 

input on the scope and implementation 

of potential expanded access programs 

with direct-acting antiviral agents 

(DAAs) for the treatment of chronic 

hepatitis C (CHC) infection in patients 

with unmet medical need. This public 

hearing is being held to obtain 

comments from the public on eligibility 

criteria that should be used for patient 

enrollment in expanded access 

protocols involving DAAs and to elicit 

suggestions for designs of protocols for 

treatment investigational new drug 

applications (INDs) involving DAAs and 

other expanded access protocols. In 

addition, the agency would like public 

input on types of studies that should be 

conducted to obtain information on 

patients with unmet medical need 

including those with the greatest risk of 

progression of liver disease and/or the 

lowest predicted virologic response 

rates. 

DATES: The public hearing will be held 

April 30, 2010, from 9 a.m. to 4 p.m. 

The meeting may be extended or may 

end early depending on the level of 

public participation. Submit written or 

electronic requests for oral presentations 

and comments by April 8, 2010 (see 

section III of this document for details). 

Written or electronic comments will be 

accepted after the hearing until June 25, 

2010 (see section V of this document for 

details). 

ADDRESSES: The public hearing will be 

held at the Hilton Hotel, 1750 Rockville 

Pike, Rockville, MD 20852. Additional 

information on parking and public 

transportation may be accessed at http:// 


erowe on DSK5CLS3C1PROD with NOTICES